Find the Perfect Plan for Your Investment Journey
O
Latest price
52 Week Range
€0.85 - €1.16
Next Earnings Date
Apr 29 2025
Next Earnings Date
Apr 29 2025
Latest price
Market Cap | - |
EV | - |
Shares Outstanding | - |
Beta | - |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €1.15 |
P/E 2025E | 15.06x |
P/Revenue 2025E | 0.10x |
Revenue | -3.70% |
EPS | - |
Operating Cash Flow | -1.10% |
Free Cash Flow | 27.80% |
Revenue | 4.90% |
EPS | - |
Operating Cash Flow | -2.40% |
Free Cash Flow | -17.90% |
Gross Margin 2025E | 9.55% |
Net Profit Margin 2025E | 0.58% |
ROE 2025E | 7.63% |
ROCE 2024 | -13.19% |
DPS 2025E | €0.07 |
Payout Ratio 2025E | 100.00% |
Div. Yield 2025E | 7.11% |
DPS Last 3Y CAGR | 20.50% |
Price
%
1M
3M
6M
1Y
3Y
5Y
O
Oriola Oyj
OKDBV
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Gabrielson, Katarina
Employees
Website
oriola.comIPO Date
2006-07-03
Headquarters
Orionintie 5, Espoo, Uusimaa, 02200, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved